Madison Avenue Partners, LP Ovid Therapeutics Inc. Transaction History
Madison Avenue Partners, LP
- $626 Million
- Q4 2024
A detailed history of Madison Avenue Partners, LP transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 3,722,627 shares of OVID stock, worth $2.12 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
3,722,627
Previous 4,116,773
9.57%
Holding current value
$2.12 Million
Previous $4.86 Million
28.72%
% of portfolio
0.55%
Previous 0.6%
Shares
8 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
40.7MCall Options Held
2.4KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$3.03 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$2.28 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.2 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.15MShares$1.79 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.85MShares$1.62 Million0.12% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $40.1M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...